Skip to main content

Table 4 Estimated 3-year savings (Hours, FTEs, Costs) from switching 50% to 75% of treated patients with PID/SID from hospital IVIg to home SCIg in Canada by province

From: Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada

Province

Savings with 50% switch rate

Savings with 75% switch rate

 

Hours

FTEs

Labor costs (C$ millions)

Hours

FTEs

Labor costs (C$ millions)

Alberta

44,969

24.8

$ 2.59

67,453

37.2

$ 3.88

British Columbia

53,662

29.6

$ 3.09

80,493

44.4

$ 4.64

Quebec

93,506

51.6

$ 5.38

140,258

77.4

$ 8.08

Manitoba

14,708

8.1

$ 0.85

22,062

12.2

$ 1.27

New Brunswick

8,776

4.8

$ 0.51

13,164

7.3

$ 0.76

Newfoundland & Labrador

5,952

3.3

$ 0.34

8,928

4.9

$ 0.51

Nova Scotia

11,013

6.1

$ 0.63

16,520

9.1

$ 0.95

Ontario

156,786

86.5

$ 9.03

235,179

129.7

$ 13.54

Prince Edward Island

1,696

0.9

$0.10

2,544

1.2

$ 0.15

Saskatchewan

12,537

6.9

$ 0.72

18,806

10.4

$ 1.08

Territories

1,313

0.7

$ 0.08

1,969

1.1

$ 0.11

Total

404,918

223.3

$ 23.30

607,376

335.0

$ 34.98